Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Soc.Bol SIBE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Laboratorios Farmaceuticos Rovi SA

+ Add to Watchlist

ROVI:SM

13.9900 EUR 0.2100 1.52%

As of 06:56:11 ET on 03/05/2015.

Snapshot for Laboratorios Farmaceuticos Rovi SA (ROVI)

Open: 13.7800 Day's Range: 13.7800 - 14.0000 Volume: 900
Previous Close: 13.7800 52wk Range: 7.9000 - 15.0000 1-Yr Rtn: +42.56%

Stock Chart for ROVI

No chart data available.
  • ROVI:SM 13.9900
  • 1D
  • 1M
  • 1Y
13.7800
Interactive ROVI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ROVI

Current P/E Ratio (ttm) 28.8944
Estimated P/E(12/2015) 25.6066
Relative P/E vs. IBEX 1.2398
Earnings Per Share (EUR) (ttm) 0.4821
Est. EPS (EUR) (12/2015) 0.5440
Est. PEG Ratio 1.5905
Market Cap (M EUR) 696.50
Shares Outstanding (M) 50.00
30 Day Average Volume 69,326
Price/Book (mrq) 4.6276
Price/Sale (ttm) 2.9385
Dividend Indicated Gross Yield 1.21%
Cash Dividend (EUR) 0.1352
Dividend Ex-Date
5 Year Dividend Growth 12.42%
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ROVI

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ROVI

Laboratorios Farmaceuticos Rovi SA is a specialty pharmaceutical company. The Company researches, develops, manufactures, and markets small molecule and specialty biologic drugs. Rovi's services include contract manufacturing of aseptic filling and packaging of small-volume parenterals in prefilled syringes and vials and provides temperature-controlled storage facilities.

Juan Lopez-Belmonte LopezChairman/Co-CEOEnrique Castellon LealVice Chairman
Juan Lopez-Belmonte EncinaCo-CEO/General DirectorJavier Lopez-Belmonte EncinaChief Financial Officer
More Company Profile & Key Executives for ROVI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil